Nevertheless, our results from studies using human cell line models and pre-malignant tissues suggest that MILIP may contribute to c-Myc-driven neoplastic transformation, and MILIP may therefore represent a potential anti-cancer target for counteracting the c-Myc-axis. This evidence concerns the gene MILIP and cancer.